Antiphospholipid Syndrome and the Kidney

Seminars in Nephrology

Volumn 35, Issue 5, 2015, Pages 478-486

  Sciascia, Savino ^a,b   Baldovino, Simone ^a   Schreiber, Karen ^b,c   Solfietti, Laura ^a   Roccatello, Dario ^a,d  

^a UNIVERSITY OF TURIN   (Italy)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c Mental Health Center Glostrup   (Denmark)

^d MOLINETTE HOSPITAL   (Italy)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; APS nephropathy; Thrombosis

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; KIDNEY DISEASE; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; MICROTHROMBUS; PHARMACEUTICAL CARE; PREGNANCY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; CHRONIC KIDNEY FAILURE; FEMALE; IMMUNOLOGY; KIDNEY; PREGNANCY COMPLICATION;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; PREGNANCY; PREGNANCY COMPLICATIONS; THROMBOSIS;

EID: 84961620932     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2015.08.009     Document Type: Review

References (51)

1. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
2. Worrall J.G., Snaith M.L., Batchelor J.R., et al. SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up. QJM 1990, 74:319-330.
3. Estes D., Christian C.L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971, 50:85-95.
4. Rovin B.H., Parikh S.V. Lupus nephritis: the evolving role of novel therapeutics. Am J Kidney Dis 2014, 63:677-690.
5. Ruiz-Irastorza G., Crowther M., Branch W., et al. Antiphospholipid syndrome. Lancet 2010, 376:1498-1509.
6. Cervera R., Serrano R., Pons-Estel G.J., et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 2015, 74:1011-1018.
7. Stone S., Pijnenborg R., Vercruysse L., et al. The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta 2006, 27:457-467.
8. Cervera R., Tektonidou M.G., Espinosa G., et al. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus 2011, 20:165-173.
9. Stone S., Langford K., Nelson-Piercy C., et al. Antiphospholipid antibodies do not a syndrome make. Lupus 2002, 11:130-133.
10. Meroni P.L., Borghi M.O., Raschi E., et al. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 2011, 7:330-339.
11. Meroni P.L., Riboldi R. Pathogenic mechanisms mediating antiphospholipid syndrome. Curr Opin Rheumatol 2001, 13:377-382.
12. Sciascia S., Cuadrado M.J., Khamashta M., et al. Renal involvement in antiphospholipid syndrome. Nat Rev Nephrol 2014, 10:279-289.
13. Giannakopoulos B., Krilis S.A. The pathogenesis of the antiphospholipid syndrome. N Engl J Med 2013, 368:1033-1044.
14. Sciascia S., Sanna G., Murru V., et al. GAPSS: the Global Anti-Phospholipid Syndrome Score. Rheumatology (Oxford) 2013, 52:1397-1403.
15. Lie J.T. Vasculitis in the antiphospholipid syndrome: culprit or consort?. J Rheumatol 1994, 21:397-399.
16. Amigo M.C., Garcia-Torres R., Robles M., et al. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992, 19:1181-1185.
17. Sinico R.A., Cavazzana I., Nuzzo M., et al. Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients. Clin J Am Soc Nephrol 2010, 5:1211-1217.
18. Tektonidou M.G., Sotsiou F., Nakopoulou L., et al. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 2004, 50:2569-2579.
19. Daugas E., Nochy D., Huong D.L., et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 2002, 13:42-52.
20. Uthman I., Khamashta M. Antiphospholipid syndrome and the kidneys. Semin Arthritis Rheum 2006, 35:360-367.
21. Griffiths M.H., Papadaki L., Neild G.H. The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury. QJM 2000, 93:457-467.
22. Rankin E.C., Nield G.H., Isenberg D.A. Deterioration of renal function in a patient with lupus. Ann Rheum Dis 1994, 53:67-71.
23. Alchi B., Griffiths M., Jayne D. What nephrologists need to know about antiphospholipid syndrome. Nephrol Dial Transplant 2010, 25:3147-3154.
24. Barbour T., Johnson S., Cohney S., et al. Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant 2012, 27:2673-2685.
25. Bertolaccini M.L., Amengual O., Andreoli L., et al. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev 2014, 13:917-930.
26. Asherson R.A., Espinosa G., Cervera R., et al. Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment. J Clin Rheumatol 2002, 8:157-165.
27. Nochy D., Daugas E., Droz D., et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 1999, 10:507-518.
28. Bhandari S., Harnden P., Brownjohn A.M., et al. Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. QJM 1998, 91:401-409.
29. Zheng H., Chen Y., Ao W., et al. Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases. Arthritis Res Ther 2009, 11:R93.
30. Miranda J.M., Garcia-Torres R., Jara L.J., et al. Renal biopsy in systemic lupus erythematosus: significance of glomerular thrombosis. Analysis of 108 cases. Lupus 1994, 3:25-29.
31. Ruiz-Irastorza G., Egurbide M.V., Ugalde J., et al. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Arch Intern Med 2004, 164:77-82.
32. Moroni G., Ventura D., Riva P., et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis 2004, 43:28-36.
33. Pérez Velásquez C., Isenberg D., Croca S. Secondary antiphospholipid syndrome nephropathy and lupus nephritis: a case-control study [abstract THU0308]. Ann Rheum Dis 2013, 72(Suppl 3):270.
34. Kwok L.W., Tam L.S., Zhu T., et al. Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus. Lupus 2011, 20:829-836.
35. Smyth A., Oliveira G.H., Lahr B.D., et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 2010, 5:2060-2068.
36. Kincaid-Smith P., Fairley K.F., Kloss M. Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. QJM 1988, 68:795-815.
37. Kincaid-Smith P. Post partum renal failure in systemic lupus erythematosus associated with circulating lupus anticoagulant and anticardiolipin antibody. Clin Nephrol 1991, 36:52.
38. Ruiz-Irastorza G., Cuadrado M.J., Ruiz-Arruza I., et al. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus 2011, 20:206-218.
39. Erkan D., Aguiar C.L., Andrade D., et al. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. Autoimmun Rev 2014, 13:685-696.
40. Tektonidou M.G., Laskari K., Panagiotakos D.B., et al. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum 2009, 61:29-36.
41. Sangle S.R., D'Cruz D.P., Abbs I.C., et al. Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. Rheumatology (Oxford) 2005, 44:372-377.
42. Korkmaz C., Kabukcuoğlu S., Isiksoy S., et al. Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy. Lupus 2003, 12:760-765.
43. Brodsky S.V., Nadasdy T., Rovin B.H., et al. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 2011, 80:181-189.
44. Sokunbi D.O., Miller F., Wadhwa N.K., et al. Reversible renal failure in the primary antiphospholipid syndrome--a report of two cases. J Am Soc Nephrol 1993, 4:28-35.
45. Sciascia S., Giachino O., Roccatello D. Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin. Clin Exp Rheumatol 2012, 30:409-413.
46. Sciascia S., Breen K., Hunt B.J. Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism. Blood Coagul Fibrinolysis 2015, 26:476-477.
47. Giles I., Khamashta M., D'Cruz D., et al. A new dawn of anticoagulation for patients with antiphospholipid syndrome?. Lupus 2012, 21:1263-1265.
48. Sciascia S., Naretto C., Rossi D., et al. Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome. Lupus 2011, 20:1106-1108.
49. Erkan D., Vega J., Ramón G., et al. A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis Rheum 2013, 65:464-471.
50. Erkan D., Lockshin M.D. New approaches for managing antiphospholipid syndrome. Nat Clin Pract Rheumatol 2009, 5:160-170.
51. Velik-Salchner C., Lederer W., Wiedermann F. Eculizumab and renal transplantation in a patient with catastrophic antiphospholipid syndrome: effect of heparin on complement activation. Lupus 2011, 20:772.